Showing results (541-550 of 549) with videos related to
Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 549 results.
Nature Medicine|June 26, 2012
Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicityHartmut Geiger, Snehalata A Pawar, Edward J Kerschen, et al.Nature Communications|August 27, 2022
Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expressionMoh'd Mohanad Al-Dabet, Khurrum Shahzad, Ahmed Elwakiel, et al.The Journal of Trauma and Acute Care Surgery|May 15, 2026
Characterization of the binding of skeletal muscle myosin to fibrin in traumaChih Jen Yang, Amelia A Rodolf, Joseph P Garay, et al.Nature Cardiovascular Research|November 25, 2022
Generation and Comparative Analysis of an Itga8-CreER Mouse with Preferential Activity in Vascular Smooth Muscle CellsGanesh Warthi, Jessica L Faulkner, Jaser Doja, et al.Journal of Thrombosis and Haemostasis : JTH|March 28, 2025
Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein SRaja Prince Eladnani, Ute Schaeper, Rim Diab, et al.Annals of Neurology|November 20, 2018
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic StrokePatrick Lyden, Kent E Pryor, Christopher S Coffey, et al.The Lancet. Gastroenterology & Hepatology|May 17, 2017
Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studiesGautam Goel, Tim King, A James Daveson, et al.Nature Communications|January 10, 2015
Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindnessS Kmoch, J Majewski, V Ramamurthy, et al.Journal of Medicinal Chemistry|January 4, 2018
Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune DiseasesMichael L Vazquez, Neelu Kaila, Joseph W Strohbach, et al.Pageof 55